Oncology Evidence Analysis Team

Expert Workgroup
Christina W. Biesemeier, MS, RD, LD, FADA, LDN (co- chair)
Laura G. Elliott, MPH, RD, CSO, LD, (co- chair)
Carol B. Frankmann, MS, RD, LD, CNSD
Dianne E. Kiyomoto, RD, CSO
Kimberly Robien, PhD, RD, FADA, CNSD
Denise Snyder, MS, RD, LDN

Former Workgroup Member
Sandra Luthringer, RD, LDN

Project Manager
Tami A. Piemonte, MS, RD, LDN

Lead Evidence Analysts
Jeanene J. Fogli, MS, RD, LD
Mary Katherine 'Kathy' Hoy, EdD, RD
Maureen B. Huhmann, MS, RD
Marianne Grandon, RD, LD
Lori A. Neighbors, MS, RD
Joanne M. Spahn, MS, RD, FADA
Kyle L. Thompson, MS, RD, CD
Toni M. Tucker, MA, RD

*During the course of the project, lead analysts also worked as analysts

Evidence Analysts
Sheila M. Campbell, PhD, RD, LD
Amanda G. Carlson, MS, RD
Lisa Davis, MS, RD
Erica R. Dean, MS, RD, LD
Debby Demory-Luce, PhD, RD, LD
Suzanne W. Dixon, MPH, MS, RD
Mable L. Everette, PhD, MPH, RD, FADA
Suzanne Brodney-Folse, PhD, RD
Cynthia M. Goody, PhD, RD, LD
Christina M. Kearns, MS, RD
Kathryn S. Keim, PhD, RD, LDN
Lori L. Kundra, MS, RD, LDN
Jeannine B. Mills, MS, RD, LD
Jennifer K. Nelson, MS, RD
Donna Perisee McFarlane, MD
Felicia L. Rocchi, PhD, MEd, RD, LDN
Catherine B. Scanlon, MS, RD, LD
Linda F. Tate, MS, RD, LD
Janet G. Yarrow, MS, RD

Reviewers
Ethan Bergman, PhD, RD, CD, FADA
Jo Ann Carson, PhD, RD, LD
Nancy M. Copperman, MS, RD
Rachael C. Drabot, MPH, CNSD, RD, LD
David Frankenfield, MS, RD
M. Patricia Fuhrman, MS, RD, LD, FADA
Gretchen M. Garlow, RD, CNSD
Jennifer C. Graf, MS, RD
Ken Hance, PhD
Wahida Karmally, DrPH, RD, CDE, CLS
Sue Kent, MS, RD, LD
Greta C. Macaire, RD
Kathleen C. Niedert, MBA, RD, CSG, LD, FADA
Jessie Pavlinac, MS, RD, CSR, LD
Christine G. Salaita, MS, RD
Harold Seifried, PhD
Marge Whitman, MS, AOCNS, RN

Financial Contributors
Academy of Nutrition and Dietetics (formerly American Dietetic Association)
Novartis

Academy Staff
Deborah Cummins, PhD
Kari Kren, MPH, RD
Esther F. Myers, PhD, RD

---

Disclosures of Potential Conflict of Interest: In the interest of full disclosure, the Academy has adopted the policy of revealing relationships workgroup members have with companies that sell products or services that are relevant to this topic. Workgroup members are required to disclose potential conflicts of interest by completing the Academy Conflict of Interest Form. It should not be assumed that these financial interests will have an adverse impact on the content, but they are noted here to fully inform readers. None of the work group members listed above disclosed potential conflicts of interest.

Note: The Academy acknowledges and is grateful for support from financial contributors; however the Academy’s Research and Strategic Business Development staff maintains full control over the content and process of all evidence analysis projects including the selection of topics, evaluation of research, assignment of grades, and development of recommendations.

---

The Academy Oncology Workgroup Members

Most of the work group meetings are teleconferences and many hours are spent on the telephone. Laura, Dianne, and Chris, oncology project work group members, are pictured above during the April 2007 Guideline Development Meeting.